FindTrial
Sign In

an exploratory trial of prospecively monitoring ctDNA with BR NGS panel (LungPlasma) in patients with advanced NSCLC

an exploratory trial of prospecively monitoring ctDNA with BR NGS panel (LungPlasma) in patients with advanced NSCLC

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDD-16008065
Enrollment
Unknown
Registered
2016-03-07
Start date
2016-04-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-Small Cell Lung Cancer

Interventions

Gold Standard:
Index test:

Sponsors

The First Affiliated Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: advanced NSCLC

Exclusion criteria

Exclusion criteria: driver gene unknown

Design outcomes

Primary

MeasureTime frame
accuracy;—

Countries

China

Contacts

Public ContactZhicheng Zhou

The First Affiliated Hospital of Guangzhou Medical University

doctorzcz@163.com+86 13560351186

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026